John Wiley & Sons, Inc.
Disclosing study outcomes to participants may backfire
Published in Mental Health Business Week, April 8th, 2006
Published in a recent issue of Cancer, the commentary suggests investigators have an ethical obligation to minimize harm to participants by providing participants only the study data that will directly benefit their future care, and by giving them an option to read and discuss the results as they pertain to their own disease management.
Current ethical practices in research emphasize protecting patient rights...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Business Week
More Articles from Mental Health Business Week
- Cortex Pharmaceuticals, Inc.
Adult ADHD study with CX717 shows positive results, reports Cortex - Neurogen Corporation
Neurogen Corporation announces $10.6 million net loss for the fourth quarter of 2005 - Neuromed Pharmaceuticals Ltd.
Neuromed raises US$25 million, completing fourth-round private equity financing - Nordic Naturals, Inc.
Nutritional and program interventions improve functional behaviors among Mexican orphans - StemCells, Inc.
Oregon IRB approves phase 1 trial using purified human neural stem cells in Batten disease - Amarin Corp. plc
Amarin reports Miraxion improves stress hormone transport - More from this issue of Mental Health Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
